High Expression of RhoF Predicts Worse Overall Survival: A Potential Therapeutic Target for non-M3 Acute Myeloid Leukemia: Erratum

Hou, Yue; Zi, Jie; Ge, Zheng

doi:10.7150/jca.85287



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2023; 14(7):1159-1160. doi:10.7150/jca.85287 This issue Cite

Erratum

High Expression of RhoF Predicts Worse Overall Survival: A Potential Therapeutic Target for non-M3 Acute Myeloid Leukemia: Erratum

Yue Hou, Jie Zi, Zheng Ge^✉

Department of Hematology, Zhongda Hospital, Medical School of Southeast University, Institute of Hematology Southeast University, Nanjing 210009, China

Citation:

Hou Y, Zi J, Ge Z. High Expression of RhoF Predicts Worse Overall Survival: A Potential Therapeutic Target for non-M3 Acute Myeloid Leukemia: Erratum. J Cancer 2023; 14(7):1159-1160. doi:10.7150/jca.85287. https://www.jcancer.org/v14p1159.htm

Other styles

Corrected-article in J Cancer, Volume 12, 5530

Citation styles

APA

Hou, Y., Zi, J., Ge, Z. (2023). High Expression of RhoF Predicts Worse Overall Survival: A Potential Therapeutic Target for non-M3 Acute Myeloid Leukemia: Erratum. Journal of Cancer, 14(7), 1159-1160. https://doi.org/10.7150/jca.85287.

ACS

Hou, Y.; Zi, J.; Ge, Z. High Expression of RhoF Predicts Worse Overall Survival: A Potential Therapeutic Target for non-M3 Acute Myeloid Leukemia: Erratum. J. Cancer 2023, 14 (7), 1159-1160. DOI: 10.7150/jca.85287.

NLM

CSE

Hou Y, Zi J, Ge Z. 2023. High Expression of RhoF Predicts Worse Overall Survival: A Potential Therapeutic Target for non-M3 Acute Myeloid Leukemia: Erratum. J Cancer. 14(7):1159-1160.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.